img

Global Tuberculosis Testing and Diagnostics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Tuberculosis Testing and Diagnostics Market Insights, Forecast to 2034

Tuberculosis Testing and Diagnostics involve a range of medical procedures and tests used to detect and diagnose tuberculosis (TB) infections in individuals. These methods include the tuberculin skin test (TST), also known as the Mantoux test, and various blood tests that measure the immune response to TB-specific antigens. Advanced techniques like molecular tests (such as PCR) and chest X-rays can provide more accurate diagnoses, aiding in the detection of active TB infections or latent TB. Accurate TB diagnostics are crucial for timely treatment and controlling the spread of the disease.
Market Analysis and InsightsGlobal Tuberculosis Testing and Diagnostics Market
Global Tuberculosis Testing and Diagnostics market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Tuberculosis Testing and Diagnostics industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Tuberculosis Testing and Diagnostics market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Tuberculosis Testing and Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Segment by Type
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Segment by Application


Hospitals and Clinics
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Tuberculosis Testing and Diagnostics introduction, etc. Tuberculosis Testing and Diagnostics Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Tuberculosis Testing and Diagnostics
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Smear Microscopy
1.2.3 Nucleic Acid Testing
1.2.4 Radiography
1.2.5 Tuberculin Skin Test (TST)
1.2.6 Interferon Gamma Released Assay (IGRA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Testing and Diagnostics Market Perspective (2018-2033)
2.2 Global Tuberculosis Testing and Diagnostics Growth Trends by Region
2.2.1 Tuberculosis Testing and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Tuberculosis Testing and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Tuberculosis Testing and Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Tuberculosis Testing and Diagnostics Market Dynamics
2.3.1 Tuberculosis Testing and Diagnostics Industry Trends
2.3.2 Tuberculosis Testing and Diagnostics Market Drivers
2.3.3 Tuberculosis Testing and Diagnostics Market Challenges
2.3.4 Tuberculosis Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tuberculosis Testing and Diagnostics by Players
3.1.1 Global Tuberculosis Testing and Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tuberculosis Testing and Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing and Diagnostics Revenue in 2022
3.5 Global Key Players of Tuberculosis Testing and Diagnostics Head office and Area Served
3.6 Global Key Players of Tuberculosis Testing and Diagnostics, Product and Application
3.7 Global Key Players of Tuberculosis Testing and Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Testing and Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2024-2033)
5 Tuberculosis Testing and Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Tuberculosis Testing and Diagnostics Market Size (2018-2033)
6.2 North America Tuberculosis Testing and Diagnostics Market Size by Type
6.2.1 North America Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033)
6.2.3 North America Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Application
6.3.1 North America Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033)
6.3.3 North America Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
6.4 North America Tuberculosis Testing and Diagnostics Market Size by Country
6.4.1 North America Tuberculosis Testing and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Tuberculosis Testing and Diagnostics Market Size (2018-2033)
7.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type
7.2.1 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033)
7.2.3 Europe Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application
7.3.1 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033)
7.3.3 Europe Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
7.4 Europe Tuberculosis Testing and Diagnostics Market Size by Country
7.4.1 Europe Tuberculosis Testing and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tuberculosis Testing and Diagnostics Market Size (2018-2033)
8.2 China Tuberculosis Testing and Diagnostics Market Size by Type
8.2.1 China Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023)
8.2.2 China Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033)
8.2.3 China Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
8.3 China Tuberculosis Testing and Diagnostics Market Size by Application
8.3.1 China Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023)
8.3.2 China Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033)
8.3.3 China Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Tuberculosis Testing and Diagnostics Market Size (2018-2033)
9.2 Asia Tuberculosis Testing and Diagnostics Market Size by Type
9.2.1 Asia Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033)
9.2.3 Asia Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
9.3 Asia Tuberculosis Testing and Diagnostics Market Size by Application
9.3.1 Asia Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033)
9.3.3 Asia Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
9.4 Asia Tuberculosis Testing and Diagnostics Market Size by Region
9.4.1 Asia Tuberculosis Testing and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Tuberculosis Testing and Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Tuberculosis Testing and Diagnostics Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Tuberculosis Testing and Diagnostics Introduction
11.1.4 Roche Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.1.5 Roche Recent Developments
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Introduction
11.2.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.2.5 Thermo Fischer Scientific Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Introduction
11.3.4 Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.3.5 Becton Dickinson Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Tuberculosis Testing and Diagnostics Introduction
11.4.4 Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.4.5 Abbott Recent Developments
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Tuberculosis Testing and Diagnostics Introduction
11.5.4 Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.5.5 Hologic Recent Developments
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Tuberculosis Testing and Diagnostics Introduction
11.6.4 Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.6.5 Qiagen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Testing and Diagnostics Introduction
11.7.4 Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.7.5 Sanofi Recent Developments
11.8 Oxford Immunotec
11.8.1 Oxford Immunotec Company Details
11.8.2 Oxford Immunotec Business Overview
11.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Introduction
11.8.4 Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.8.5 Oxford Immunotec Recent Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Tuberculosis Testing and Diagnostics Introduction
11.9.4 BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.9.5 BioMerieux Recent Developments
11.10 Par Sterile
11.10.1 Par Sterile Company Details
11.10.2 Par Sterile Business Overview
11.10.3 Par Sterile Tuberculosis Testing and Diagnostics Introduction
11.10.4 Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.10.5 Par Sterile Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 Akonni Biosystems
11.12.1 Akonni Biosystems Company Details
11.12.2 Akonni Biosystems Business Overview
11.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Introduction
11.12.4 Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.12.5 Akonni Biosystems Recent Developments
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Tuberculosis Testing and Diagnostics Introduction
11.13.4 Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.13.5 Cepheid Recent Developments
11.14 Siemens Healthineer
11.14.1 Siemens Healthineer Company Details
11.14.2 Siemens Healthineer Business Overview
11.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Introduction
11.14.4 Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.14.5 Siemens Healthineer Recent Developments
11.15 Hain Lifescience
11.15.1 Hain Lifescience Company Details
11.15.2 Hain Lifescience Business Overview
11.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Introduction
11.15.4 Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.15.5 Hain Lifescience Recent Developments
11.16 Epistem
11.16.1 Epistem Company Details
11.16.2 Epistem Business Overview
11.16.3 Epistem Tuberculosis Testing and Diagnostics Introduction
11.16.4 Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.16.5 Epistem Recent Developments
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Introduction
11.17.4 Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023)
11.17.5 Creative Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Smear Microscopy
Table 3. Key Players of Nucleic Acid Testing
Table 4. Key Players of Radiography
Table 5. Key Players of Tuberculin Skin Test (TST)
Table 6. Key Players of Interferon Gamma Released Assay (IGRA)
Table 7. Key Players of Others
Table 8. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 9. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Tuberculosis Testing and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Tuberculosis Testing and Diagnostics Market Share by Region (2018-2023)
Table 12. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Tuberculosis Testing and Diagnostics Market Share by Region (2024-2033)
Table 14. Tuberculosis Testing and Diagnostics Market Trends
Table 15. Tuberculosis Testing and Diagnostics Market Drivers
Table 16. Tuberculosis Testing and Diagnostics Market Challenges
Table 17. Tuberculosis Testing and Diagnostics Market Restraints
Table 18. Global Tuberculosis Testing and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Tuberculosis Testing and Diagnostics Revenue Share by Players (2018-2023)
Table 20. Global Top Tuberculosis Testing and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2022)
Table 21. Global Tuberculosis Testing and Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 22. Global 5 Largest Players Market Share by Tuberculosis Testing and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Tuberculosis Testing and Diagnostics, Headquarters and Area Served
Table 24. Global Key Players of Tuberculosis Testing and Diagnostics, Product and Application
Table 25. Global Key Players of Tuberculosis Testing and Diagnostics, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2018-2023)
Table 29. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type (2024-2033)
Table 31. Global Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Tuberculosis Testing and Diagnostics Revenue Share by Application (2018-2023)
Table 33. Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Tuberculosis Testing and Diagnostics Revenue Share by Application (2024-2033)
Table 35. North America Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Tuberculosis Testing and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Tuberculosis Testing and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Tuberculosis Testing and Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 58. Asia Tuberculosis Testing and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Tuberculosis Testing and Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 65. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Tuberculosis Testing and Diagnostics Product
Table 70. Roche Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 71. Roche Recent Developments
Table 72. Thermo Fischer Scientific Company Details
Table 73. Thermo Fischer Scientific Business Overview
Table 74. Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product
Table 75. Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Thermo Fischer Scientific Recent Developments
Table 77. Becton Dickinson Company Details
Table 78. Becton Dickinson Business Overview
Table 79. Becton Dickinson Tuberculosis Testing and Diagnostics Product
Table 80. Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 81. Becton Dickinson Recent Developments
Table 82. Abbott Company Details
Table 83. Abbott Business Overview
Table 84. Abbott Tuberculosis Testing and Diagnostics Product
Table 85. Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 86. Abbott Recent Developments
Table 87. Hologic Company Details
Table 88. Hologic Business Overview
Table 89. Hologic Tuberculosis Testing and Diagnostics Product
Table 90. Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 91. Hologic Recent Developments
Table 92. Qiagen Company Details
Table 93. Qiagen Business Overview
Table 94. Qiagen Tuberculosis Testing and Diagnostics Product
Table 95. Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 96. Qiagen Recent Developments
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Tuberculosis Testing and Diagnostics Product
Table 100. Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 101. Sanofi Recent Developments
Table 102. Oxford Immunotec Company Details
Table 103. Oxford Immunotec Business Overview
Table 104. Oxford Immunotec Tuberculosis Testing and Diagnostics Product
Table 105. Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 106. Oxford Immunotec Recent Developments
Table 107. BioMerieux Company Details
Table 108. BioMerieux Business Overview
Table 109. BioMerieux Tuberculosis Testing and Diagnostics Product
Table 110. BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 111. BioMerieux Recent Developments
Table 112. Par Sterile Company Details
Table 113. Par Sterile Business Overview
Table 114. Par Sterile Tuberculosis Testing and Diagnostics Product
Table 115. Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 116. Par Sterile Recent Developments
Table 117. Bio-Rad Laboratories Company Details
Table 118. Bio-Rad Laboratories Business Overview
Table 119. Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product
Table 120. Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 121. Bio-Rad Laboratories Recent Developments
Table 122. Akonni Biosystems Company Details
Table 123. Akonni Biosystems Business Overview
Table 124. Akonni Biosystems Tuberculosis Testing and Diagnostics Product
Table 125. Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 126. Akonni Biosystems Recent Developments
Table 127. Cepheid Company Details
Table 128. Cepheid Business Overview
Table 129. Cepheid Tuberculosis Testing and Diagnostics Product
Table 130. Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 131. Cepheid Recent Developments
Table 132. Siemens Healthineer Company Details
Table 133. Siemens Healthineer Business Overview
Table 134. Siemens Healthineer Tuberculosis Testing and Diagnostics Product
Table 135. Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 136. Siemens Healthineer Recent Developments
Table 137. Hain Lifescience Company Details
Table 138. Hain Lifescience Business Overview
Table 139. Hain Lifescience Tuberculosis Testing and Diagnostics Product
Table 140. Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 141. Hain Lifescience Recent Developments
Table 142. Epistem Company Details
Table 143. Epistem Business Overview
Table 144. Epistem Tuberculosis Testing and Diagnostics Product
Table 145. Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 146. Epistem Recent Developments
Table 147. Creative Diagnostics Company Details
Table 148. Creative Diagnostics Business Overview
Table 149. Creative Diagnostics Tuberculosis Testing and Diagnostics Product
Table 150. Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2018-2023) & (US$ Million)
Table 151. Creative Diagnostics Recent Developments
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Tuberculosis Testing and Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Smear Microscopy Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Radiography Features
Figure 6. Tuberculin Skin Test (TST) Features
Figure 7. Interferon Gamma Released Assay (IGRA) Features
Figure 8. Others Features
Figure 9. Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 10. Global Tuberculosis Testing and Diagnostics Market Share by Application: 2022 VS 2033
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Others Case Studies
Figure 14. Tuberculosis Testing and Diagnostics Report Years Considered
Figure 15. Global Tuberculosis Testing and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Tuberculosis Testing and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Tuberculosis Testing and Diagnostics Market Share by Region: 2022 VS 2033
Figure 18. Global Tuberculosis Testing and Diagnostics Market Share by Players in 2022
Figure 19. Global Top Tuberculosis Testing and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing and Diagnostics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Tuberculosis Testing and Diagnostics Revenue in 2022
Figure 21. North America Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
Figure 23. North America Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
Figure 24. North America Tuberculosis Testing and Diagnostics Market Share by Country (2018-2033)
Figure 25. United States Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Tuberculosis Testing and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
Figure 29. Europe Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
Figure 30. Europe Tuberculosis Testing and Diagnostics Market Share by Country (2018-2033)
Figure 31. Germany Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China Tuberculosis Testing and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
Figure 39. China Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
Figure 40. Asia Tuberculosis Testing and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
Figure 42. Asia Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
Figure 43. Asia Tuberculosis Testing and Diagnostics Market Share by Region (2018-2033)
Figure 44. Japan Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America Tuberculosis Testing and Diagnostics Market Share by Country (2018-2033)
Figure 54. Brazil Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries Tuberculosis Testing and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Roche Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 61. Thermo Fischer Scientific Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 62. Becton Dickinson Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 63. Abbott Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 64. Hologic Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 65. Qiagen Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 66. Sanofi Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 67. Oxford Immunotec Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 68. BioMerieux Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 69. Par Sterile Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 70. Bio-Rad Laboratories Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 71. Akonni Biosystems Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 72. Cepheid Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 73. Siemens Healthineer Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 74. Hain Lifescience Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 75. Epistem Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 76. Creative Diagnostics Revenue Growth Rate in Tuberculosis Testing and Diagnostics Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed